Drug intelligence / Profile preview

thebacon

Development stage
Unknown
Lead developer
Boehringer Ingelheim
Modality
Small Molecules
Administration
Oral
01

Overview

Thebacon is a semisynthetic opioid analgesic and antitussive of the morphinan class, structurally related to hydrocodone and codeine. It acts primarily as an opioid receptor agonist, exerting its effects mainly through conversion in the liver to more potent opioids such as hydromorphone via CYP2D6 metabolism. Thebacon has slightly higher potency than hydrocodone and is approximately eight times stronger than codeine by weight. It was formerly used in Europe under brand names like Acedicon for pain relief and cough suppression but is now rarely used clinically. In the United States, it is classified as a Schedule I controlled substance due to its high abuse potential and lack of accepted medical use[1][2][3][7].

Brand names
Acedicon
Other names
thebacontebaconacetyldihydrocodeinonethebaconeacedikondihydrocodeinone enol acetatedemethyldihydrothebaine acetate
02

Targets

DOR (Opioid Receptor Delta 1)KOR (Kappa opioid receptor)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on thebacon.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on thebacon.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call